Bleomycin A6

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Bleomycin A6
Accession Number
DB12992
Type
Small Molecule
Groups
Investigational
Description

Bleomycin A6 has been used in trials studying the treatment of Squamous Cell Lung Cancer.

Synonyms
  • Boanmycin
  • Pingyangmycin A6
  • Zhengguangmycin A6
Categories
UNII
0B19OCB220
CAS number
37293-17-7
Weight
Not Available
Chemical Formula
Not Available
InChI Key
Not Available
InChI
Not Available
IUPAC Name
Not Available
SMILES
Not Available

Pharmacology

Indication
Not Available
Structured Indications
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
PubChem Substance
347911414

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
2Unknown StatusTreatmentSquamous Cell Carcinoma of Lung1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
Not Available
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Taxonomy

Classification
Not classified

Drug created on October 20, 2016 19:50 / Updated on November 06, 2017 06:47